About Us
-
About the University
-
Department History
-
»
Message from Chair
|
Message from Chair
Greetings,
I welcome your virtual visit to our department within the University of Pennsylvania’s School of Medicine. Ours is one of the elite, fully-integrated departments of pathology in the country, bringing together the full gamut of clinical services and research interests. Six divisions constitute its thematic pillars: Anatomic Pathology, Neuropathology, Laboratory Medicine, Transfusion Medicine, Pediatric Pathology, and Experimental Pathology & Immunobiology.
Through these divisions, we embrace the classical tripartite mission of academic pathology departments by spanning the patient care, investigative, and educational enterprises. Leveraging the hospitals and outreach network of the University of Pennsylvania Health System, our department showcases broad-ranging clinical subspecialty expertise which encompasses forefront diagnostic test development and infusional therapeutics innovation. Our research programs feature dynamic and interdisciplinary interplay between basic and translational research, with consistent funding success. On the education side, we take great pride in hosting one of the leading pathology residency programs in the country, as well as to a rich array of clinical and postdoctoral research fellowships.
As for tomorrow, we look to a bright future for our discipline with great excitement. The early 21st century is ushering in a revolution in diagnostics and therapeutics, and pathology departments will be key drivers for paradigm-shifting in both. We at Penn are positioned to fully engage the constellation of emerging molecular and imaging technologies that place pathology departments at the nexus of patient-tailored therapies, ultra-sensitive early disease detection and post-procedure monitoring, and clinical bioinformatics.
We are nurturing programs that will dovetail with the changing technological face of our discipline, as nanodiagnostics, pathology-radiology convergence, highly multiplexed clinical testing, and telepathology beckon us. We are positioning our transfusion medicine services to help introduce and innovate a growing armamentarium of biologics (cellular, protein and gene therapies). And in this post-genomics landscape, we envision experimental pathologists as being conceptually and operationally equipped to probe the pathogenesis continuum from molecule to whole organism, doing sowith an assortment of new experimental capabilities, from protein structural modeling to probing in vivo pathophysiologic dynamics.
Along the way, we welcome our vital partnership with you.
Mark L. Tykocinski, MD
Simon Flexner Professor and Chair
|
